Verified Market Research®, a leading provider of business intelligence and market analysis is thrilled to announce the release of its comprehensive and authoritative report on the RNA Therapeutics ...

Capricor Therapeutics, Inc.’s CAPR share price has dipped by 10.45%, which has investors questioning if this is right time to ...

Avidity Biosciences, Inc. (NASDAQ:RNA – Get Free Report) has received a consensus rating of “Buy” from the thirteen research ...

SHANGHAI, China I March 17, 2025 I Rona Therapeutics Inc., a global leader in RNA-targeted therapeutics, announced the clearance of an Investigational New ...

With CSL Seqirus and Arcturus Therapeutics successfully developing the first approved self-amplifying RNA vaccine, the field of next generation RNAs celebrates the potential of circular and self ...

BioMarin Pharmaceutical reported revenues of $747.3 million, up 15.6% year on year. This print exceeded analysts’ ...

Merger Completion: On August 15, 2024, Silexion completed its business combination with Moringa Acquisition Corp, becoming a publicly traded company on Nasdaq under the ticker “SLXN.” This strategic ...

Sarepta Therapeutics (NASDAQ:SRPT – Get Free Report) had its price target reduced by stock analysts at Deutsche Bank ...

We gleaned this information from our observations today when Benzinga's options scanner highlighted 11 extraordinary options ...

Q4 2024 Earnings Call Transcript March 18, 2025 MiNK Therapeutics, Inc. misses on earnings expectations. Reported EPS is ...